Literature DB >> 25659891

Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kDa to ensure proper abscission.

Nicole St-Denis1, Gagan D Gupta1, Zhen Yuan Lin1, Beatriz Gonzalez-Badillo1, Laurence Pelletier2, Anne-Claude Gingras3.   

Abstract

The myotubularins are a family of phosphatases that dephosphorylate the phosphatidylinositols phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-phosphate. Several family members are mutated in disease, yet the biological functions of the majority of myotubularins remain unknown. To gain insight into the roles of the individual enzymes, we have used affinity purification coupled to mass spectrometry to identify protein-protein interactions for the myotubularins. The myotubularin interactome comprises 66 high confidence (false discovery rate ≤1%) interactions, including 18 pairwise interactions between individual myotubularins. The results reveal a number of potential signaling contexts for this family of enzymes, including an intriguing, novel role for myotubularin-related protein 3 and myotubularin-related protein 4 in the regulation of abscission, the final step of mitosis in which the membrane bridge remaining between two daughter cells is cleaved. Both depletion and overexpression of either myotubularin-related protein 3 or myotubularin-related protein 4 result in abnormal midbody morphology and cytokinesis failure. Interestingly, myotubularin-related protein 3 and myotubularin-related protein 4 do not exert their effects through lipid regulation at the midbody, but regulate abscission during early mitosis, by interacting with the mitotic kinase polo-like kinase 1, and with centrosomal protein of 55 kDa (CEP55), an important regulator of abscission. Structure-function analysis reveals that, consistent with known intramyotubularin interactions, myotubularin-related protein 3 and myotubularin-related protein 4 interact through their respective coiled coil domains. The interaction between myotubularin-related protein 3 and polo-like kinase 1 relies on the divergent, nonlipid binding Fab1, YOTB, Vac1, and EEA1 domain of myotubularin-related protein 3, and myotubularin-related protein 4 interacts with CEP55 through a short GPPXXXY motif, analogous to endosomal sorting complex required for transport-I components. Disruption of any of these interactions results in abscission failure, by disrupting the proper recruitment of CEP55, and subsequently, of endosomal sorting complex required for transport-I, to the midbody. Our data suggest that myotubularin-related protein 3 and myotubularin-related protein 4 may act as a bridge between CEP55 and polo-like kinase 1, ensuring proper CEP55 phosphorylation and regulating CEP55 recruitment to the midbody. This work provides a novel role for myotubularin-related protein 3/4 heterodimers, and highlights the temporal and spatial complexity of the regulation of cytokinesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25659891      PMCID: PMC4390272          DOI: 10.1074/mcp.M114.046086

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  71 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.

Authors:  Hope Dang; Zhai Li; Edward Y Skolnik; Hanna Fares
Journal:  Mol Biol Cell       Date:  2003-10-17       Impact factor: 4.138

3.  A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

Authors:  D M Keller; X Zeng; Y Wang; Q H Zhang; M Kapoor; H Shu; R Goodman; G Lozano; Y Zhao; H Lu
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate.

Authors:  R Zhao; Y Qi; J Chen; Z J Zhao
Journal:  Exp Cell Res       Date:  2001-05-01       Impact factor: 3.905

5.  Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity.

Authors:  D M Walker; S Urbé; S K Dove; D Tenza; G Raposo; M J Clague
Journal:  Curr Biol       Date:  2001-10-16       Impact factor: 10.834

6.  Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction.

Authors:  Kazuya Tsujita; Toshiki Itoh; Takeshi Ijuin; Akitsugu Yamamoto; Assia Shisheva; Jocelyn Laporte; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

Review 7.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

8.  Polo-like kinase is a cell cycle-regulated kinase activated during mitosis.

Authors:  R Hamanaka; M R Smith; P M O'Connor; S Maloid; K Mihalic; J L Spivak; D L Longo; D K Ferris
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

9.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2.

Authors:  A Bolino; M Muglia; F L Conforti; E LeGuern; M A Salih; D M Georgiou; K Christodoulou; I Hausmanowa-Petrusewicz; P Mandich; A Schenone; A Gambardella; F Bono; A Quattrone; M Devoto; A P Monaco
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

10.  Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.

Authors:  R M Golsteyn; K E Mundt; A M Fry; E A Nigg
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  7 in total

1.  Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.

Authors:  Xu Li; Kim My Tran; Kathryn E Aziz; Alexey V Sorokin; Junjie Chen; Wenqi Wang
Journal:  Mol Cell Proteomics       Date:  2016-07-18       Impact factor: 5.911

Review 2.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

3.  A truncating mutation in CEP55 is the likely cause of MARCH, a novel syndrome affecting neuronal mitosis.

Authors:  Patrick Frosk; Heleen H Arts; Julien Philippe; Carter S Gunn; Emma L Brown; Bernard Chodirker; Louise Simard; Jacek Majewski; Somayyeh Fahiminiya; Chad Russell; Yangfan P Liu; Robert Hegele; Nicholas Katsanis; Conrad Goerz; Marc R Del Bigio; Erica E Davis
Journal:  J Med Genet       Date:  2017-03-06       Impact factor: 6.318

4.  Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis.

Authors:  Keïs Nabhane Said Halidi; Elisabeth Fontan; Alix Boucharlat; Laurianne Davignon; Marine Charpentier; Mikaël Boullé; Robert Weil; Alain Israël; Emmanuel Laplantine; Fabrice Agou
Journal:  iScience       Date:  2019-09-25

5.  Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation.

Authors:  Devasahayam Arokia Balaya Rex; Yashwanth Subbannayya; Prashant Kumar Modi; Akhina Palollathil; Lathika Gopalakrishnan; Yashodhar P Bhandary; Thottethodi Subrahmanya Keshava Prasad; Sneha M Pinto
Journal:  Cells       Date:  2022-01-01       Impact factor: 6.600

Review 6.  The progress of research into pseudophosphatases.

Authors:  Deqiang Liu; Yiming Zhang; Hui Fang; Jinxiang Yuan; Lizhen Ji
Journal:  Front Public Health       Date:  2022-08-29

Review 7.  The Roles of Pseudophosphatases in Disease.

Authors:  Andrew M Mattei; Jonathan D Smailys; Emma Marie Wilber Hepworth; Shantá D Hinton
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.